Role of learning of open arm avoidance in the phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in mice

Life Sciences

Volumn 76, Issue 19, 2005, Pages 2235-2246

  Calzavara, M B ^a   Patti, C L ^a   Lopez, G B ^a   Abilio V C ^a   Silva, R H ^a   Frussa Filho, R ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anxiety; Chlordiazepoxide; Elevated plus maze; Learning; Tolerance

Indexed keywords

CHLORDIAZEPOXIDE; SCOPOLAMINE;

AMNESIA; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; LEARNING; LEARNING DISORDER; LIGHT; MALE; MAZE TEST; MOUSE; NOISE; NONHUMAN; TRANQUILIZING ACTIVITY;

EID: 14144251802     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.10.040     Document Type: Article

References (27)

1. S.S. Almeida, R.A. Garcia, and L.M. de Oliveira Effects of early protein malnutrition and repeated testing upon locomotor and exploratory behaviors in the elevated plus-maze Physiology Behavior 54 1993 749 752
2. L.J. Bertoglio, and A.P. Carobrez Scopolamine given pre-Trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze Trial 2 Behavioural Pharmacology 15 2004 45 54
3. F.T. Claro, R.H. Silva, and R. Frussa-Filho Bovine brain Phosphatidylserine attenuates scopolamine-induced amnesia Physiology and Behavior 67 4 1999 551 554
4. M.I. Conceição, M. Maiolini Jr., N.F. Mattia, M.A. Vital, B.R. Santos, S. Smaili, and R. Frussa-Filho Anxiety-induced antinociception in the mouse Brazilian Journal of Medical and Biological Research 25 1992 831 834
5. G.R. Dawson, S.P. Crawford, K.J. Stanhope, S.D. Iversen, and M.D. Tricklebank One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure Psychopharmacology 113 1994 570 572
6. S.E. File, P.S. Mabbutt, and P.K. Hitchcott Characterization of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze Psychopharmacology 102 1990 98 101
7. S.E. File, and H. Zagrossi Jr. "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of phobic state? Pscychopharmacology 110 1993 240 244
8. S.E. File, H. Zangrossi, M. Viana, and F.G. Graeff Trial 2 in the elevated plus-maze: a different form of fear? Psychopharmacology 111 1993 491 494
9. R. Frussa-Filho, H. Barbosa-Junior, R.H. Silva, C. Da Cunha, and C.F. Mello Naltrexone potentiates the anxiolytic effects of chlordiazepoxide in rats exposed to novel environments Psychopharmacology 147 1999 168 173
10. R. Frussa-Filho, R. Ribeiro, and A. de One-trial tolerance to the effects of chlordiazepoxide in the elevated plus-maze is not due to acquisition of phobic avoidance of open arms during initial exposure Life Sciences 71 2002 519 525
11. L.E. Gonzalez, and S.E. File A five minute experience in the elevated plus-maze alters the state of benzodiazepine receptor in the dorsal raphe nucleus Journal of Neuroscience 17 1997 1505 1511
12. G. Griebel, J.L. Moreau, F. Jenck, J.R. Martin, and R. Misslin Some critical determinants of the behaviour of rats in the elevated plus-maze Behavioral Processes 29 1993 37 48
13. A. Holmes, and R.J. Rodgers Influence of spatial and temporal manipulations of the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze Neuroscience and Biobehavioral Reviews 23 1999 971 980
14. J. Itoh, T. Nabeshima, and T. Kameyama Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice European Journal of Pharmacology 194 1991 71 76
15. C. Lee, and R.J. Rodgers Antinociceptive effects of elevated plus-maze: Influence of opiate receptor manipulations Psychopharmacology 102 1990 507 513
16. J.K.D. Pereira, R.J. Vieira, C.T. Konishi, R. Ribeiro, A. de, and R. Frussa-Filho The phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in elevated plus-maze is abolished by the introduction of a motivational conflict situation Life Sciences 65 10 1999 101 107
17. A. Platel, and R.D. Porsolt Habituation of exploratory activity in mice: a screenning test for memory enhancing drugs Psychopharmacology 78 1982 346 352
18. R.J. Rodgers, and J.C. Cole Effects of scopolamine and its quaternary analogue in the murine elevated plus-maze test of anxiety Behavioural Pharmacology 6 1995 283 289
19. R.J. Rodgers, N.J.T. Johnson, J.C. Cole, C.V. Dewar, G.R. Kidd, and P.H. Kimpson Plus-maze retest profile in mice: importance of initial stages of trail 1 and response to post-trail cholinergic receptor blockage Pharmacology, Biochemistry and Behavior 54 1996 41 50
20. R.J. Rodgers, N.J.T. Johnson, J. Carr, and T.P. Hodgson Resistance of experientially-induced changes in murine plus-maze behaviour to altered retest conditions Behavioural Brain Research 86 1997 71 77
21. R.J. Rodgers, C. Lee, and J.K. Shepherd Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience Psychopharmacology 106 1992 102 110
22. R.J. Rodgers, and J.K. Shepherd Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice Psychopharmacology 113 1993 237 242
23. A.C. Santucci, and C. Shaw Peripheral 8-OH-DPAT and scopolamine infused into the frontal cortex produce passive avoidance retention impairments in rats Neurobiology of Learning and Memory 79 2003 136 141
24. R.H. Silva, R.G. Bellot, M.A.B.F. Vital, and R. Frussa-Filho Effects of long-term ganglioside GM1 administration on a new discriminative avoidance test in normal adult mice Psychopharmacology 129 1997 322 328
25. R.H. Silva, L.F. Felicio, and R. Frussa-Filho Ganglioside GM1 attenuates scopolamine-induced amnesia in rats and mice Psychopharmacology 141 1999 111 117
26. R.H. Silva, and R. Frussa-Filho The plus-maze discriminative avoidance task: a new model to study memory-anxiety interactions. Effects of chlordiazepoxide and caffeine Journal of Neuroscience Methods 102 2000 117 125
27. D. Treit, J. Menard, and C. Royan Anxiogenic stimuli in the elevated plus-maze Pharmacology Biochemistry and Behavior 44 1993 365 370